Retrospective study investigating naloxone prescribing and cost in US Medicaid and Medicare patients.
Christopher D MankoMohamed S AhmedLavinia R HarrisonSrivastava A KodavatigantiNoelia LugoJason Osei KonaduFarrin KhanCarrie A MassariTenisha K SealeyMaame Efua AddisonCeline N MbahKenneth L McCallJoseph B FraimanBrian J PiperPublished in: BMJ open (2024)
This pronounced increase in the number of naloxone prescriptions to Medicaid patients from 2018 to 2021 indicates a national response to this widespread public health emergency. Further research into the origins of the pronounced state-level disparities is warranted.